$IMDX

$3.18 +$0.00 (0.0%) Close

$IMDX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 32.7M shares outstanding

Who owns IMDX?

By type of holder

Institutions 56.4% Insiders 0.8% Everyone else 42.8%

Concentration Top 10 holders own 132.7%

Neal C. Bradsher 39.2% · Broadwood Partners, L.P. 39.2%

Institutional ownership

56.4%

-1.4 pts vs last qtr

Institutional holders

-2 vs last qtr

Net shares bought

−473.7K

by institutions in Q2 2026

New / sold out

12 / 14

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Broadwood Capital Inc +753.0K
Family Office Research LLC +241.6K

Biggest sellers in Q2 2026

Alyeska Investment Group, L.P. SOLD OUT −840.8K
Pura Vida Investments, LLC −462.3K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Insight Molecular Diagnostics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+450.1%

+76.53% a year

Each share's claim on the business

−81.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $16.8M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years95% 3–5 years0% 1–3 years2% Under 1 year3%

Quarterly turnover

9.5%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting IMDX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
BC Broadwood Capital Inc 13D · 39.7%	12.7M	38.76%	+753.0K (+6.3%)	≤2021	3.9%
Shares held by quarter Peak holding12.7M (Q2'26) Change over 8 quarters+7.8M Share of the company38.760% Disclosed stake13D · 39.7% Broadwood Capital Inc's full portfolio →
AI AWM Investment Company, Inc.	2.8M	8.67%	+30.4K (+1.1%)	≤2021	1.5%
Shares held by quarter Peak holding2.8M (Q2'26) Change over 8 quarters+1.7M Share of the company8.670% AWM Investment Company, Inc.'s full portfolio →

Broadwood Capital Inc

13D · 39.7%

12.7M

% of company

38.76%

Change vs last qtr

+753.0K (+6.3%)

Held since

≤2021

AWM Investment Company, Inc.

2.8M

% of company

8.67%

Change vs last qtr

+30.4K (+1.1%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Insight Molecular Diagnostics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting IMDX on Form N-PORT; together they hold 3.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$2.8M	475.4K	1.45%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$1.46M	248.1K	0.76%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$2.8M

% of company

1.45%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$1.46M

% of company

0.76%

% of the fund

0.00%

As of

June 30, 2026

10 more funds behind a free account

See every fund holding Insight Molecular Diagnostics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
NC Neal C. Bradsher 5%+ holder 13D · 39.7%	12.8M	39.22%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company39.220% Disclosed stake13D · 39.7% View the 13D/G filing →
BP Broadwood Partners, L.P. 5%+ holder 13D · 39.7%	12.8M	39.22%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company39.220% Disclosed stake13D · 39.7% View the 13D/G filing →

Neal C. Bradsher

5%+ holder13D · 39.7%

12.8M

% of company

39.22%

Change vs last qtr

—

Held since

—

Broadwood Partners, L.P.

5%+ holder13D · 39.7%

12.8M

% of company

39.22%

Change vs last qtr

—

Held since

—

5 more holders behind a free account

See every insider and 5%+ holder of Insight Molecular Diagnostics Inc.

Comments